Jacqueline E. Shea
2023
In 2023, Jacqueline E. Shea earned a total compensation of $2.4M as President and Chief Executive Officer at Inovio Pharmaceuticals, a 31% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $371,280 |
---|---|
Option Awards | $812,999 |
Salary | $750,615 |
Stock Awards | $491,873 |
Other | $12,141 |
Total | $2,438,908 |
Shea received $813K in option awards, accounting for 33% of the total pay in 2023.
Shea also received $371.3K in non-equity incentive plan, $750.6K in salary, $491.9K in stock awards and $12.1K in other compensation.
Rankings
In 2023, Jacqueline E. Shea's compensation ranked 405th out of 2,918 executives tracked by ExecPay. In other words, Shea earned more than 86.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 405 | 86th |
Manufacturing | 231 | 86th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 24 | 91st |
Surgical, Medical, And Dental Instruments And Supplies | 19 | 90th |
Surgical and Medical Instruments and Apparatus | 18 | 88th |
Shea's colleagues
We found two more compensation records of executives who worked with Jacqueline E. Shea at Inovio Pharmaceuticals in 2023.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021